Frequency and extent of CD30 expression in diffuse large B-cell lymphoma and its relation to clinical and biologic factors: a retrospective study of 167 cases-Reference-Cited by-同舟云学术

Frequency and extent of CD30 expression in diffuse large B-cell lymphoma and its relation to clinical and biologic factors: a retrospective study of 167 cases

Published:2013-04-04 Issue:11 Volume:54 Page:2405-2411
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Campuzano-Zuluaga Germán¹,Cioffi-Lavina Maureen¹,Lossos Izidore S.²,Chapman-Fredricks Jennifer R.³

Affiliation:

1. Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine and Jackson Memorial Hospital, Miami, FL, USA

2. Division of Hematology-Oncology, Department of Medicine, Sylvester Comprehensive Cancer Center and Department of Molecular and Cellular Pharmacology, University of Miami, Miami, FL, USA

3. Division of Hematopathology, Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine and Jackson Memorial Hospital, Miami, FL, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.3109/10428194.2013.778407

Reference32 articles.

1. Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma

2. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

3. Jaffe ES, Harris NL, Vardiman JW, et al. Hematopathology. Philadelphia, PA: Elsevier Health Sciences; 2010.

4. Pleiotropic Signal Transduction Mediated by Human CD30: A Member of the Tumor Necrosis Factor Receptor (TNFR) Family

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brentuximab vedotin therapy followed by autologous peripheral stem cell transplantation as a viable treatment option for an older adult with transformed lymphoma: a case report and literature review;Journal of International Medical Research;2024-06

2. The synergistic immunotherapeutic impact of engineered CAR-T cells with PD-1 blockade in lymphomas and solid tumors: a systematic review;Frontiers in Immunology;2024-05-10

3. Targeting CD 30 in Lymphoid Neoplasms;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

4. Primary leptomeningeal CD30 positive diffuse large B cell lymphoma disguise as meningioma in a young adult: a case report;International Journal of Neuroscience;2024-01-25

5. A paradox of choice: Sequencing therapy in relapsed/refractory diffuse large B-cell lymphoma;Blood Reviews;2024-01